Abstract
The major route of transmission of the human immunodeficiency virus type 1 (HIV-1) worldwide, like other agents of sexually transmitted disease, is via mucosal surfaces of the genital tract through sexual exposures (1–4). It has been hypothesized that immune responses at these sites may be important determinants of protection against HIV-1 (1,2,5). Development of HIV-1 vaccines which elicit local mucosal immune responses may be critical for an effective preventive vaccine. Specific mucosal immune responses elicited after different routes of mucosal immunization in rodents have been examined previously (6–16). Nasal and oral immunization routes have elicited strong mucosal responses to HIV-1 peptides and whole proteins in mice (7,11,17,18,24). Induction of mucosal and systemic immunity to SIV and HIV-1 antigens in primates has also been obtained using a variety of mucosal routes of vaccine administration (19–22).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Mestecky, J. and Jackson, S. (1994) Reassessment of the impact of mucosal immunity in infection with the human immunodeficiency virus (HIV) and design of relevant vaccines. J. Clin. Immunol. 14, 259–272.
Miller, C. J., McGhee, J. R., and Gardner, M. B. (1993) Mucosal immunity, HIV transmission, and AIDS. Lab. Invest. 68, 129–145.
Piot, P., Plummer, F. A., Mhalu, F. S., Lamboray, J. L., Chin, J., and Mann, J. M. (1988) AIDS: an international perspective. Science 239, 573–579.
Padian, N. S., Shiboski, S. C., and Jewell, N. P. (1991) Female-to-male transmission of human immunodeficiency virus. JAMA 266, 1664–1667.
Forrest, B.D. (1991) Women, HIV, and mucosal immunity. Lancet 337, 835,836.
Haneberg, B., Kendall, D., Amerongen, H. M., Apter, F. M., Kraehenbuhl, J. P., and Neutra, M. R. (1994) Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect. Immunol. 62, 15–23.
Muster, T., Ferko, B., Klima, A., Purtscher, M., Trkola, A., Schulz, P., et al. (1995) Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus. J. Virol. 69, 6678–6686.
O’Hagan, D. T., Rafferty, D., McKeating, J. A., and Ilium, L. (1992) Vaginal immunization of rats with a synthetic peptide from human immunodeficiency virus envelope glycoprotein. J. Gen. Virol. 73, 2141–2145.
O’Hagan, D. T., McGee, J. P., Holmgren, J., Mowat, A. M., Donachie, A. M., Mills, et al. (1993) Biodegradable microparticles for oral immunization. Vaccine 11,149–154.
Orr, N., Robin, G., Cohen, D., Arnon, R., and Lowell, G. H. (1993) Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models. Infect. Immunol. 61, 2390–2395.
Staats, H. F., Nichols, W. G., and Palker, T. J. (1996) Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A). J. Immunol. 157, 464–472.
Abraham, E. and Shah, S. (1992) Intranasal immunization with liposomes containing IL-2 enhances bacterial polysaccharide antigen-specific pulmonary secretory antibody response. J. Immunol. 149, 3719–3726.
Vajdy, M. and Lycke, N. Y. (1992) Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after oral immunization. Immunology 75, 488–492.
Langermann, S., Palaszynski, S., Sadziene, A., Stover, C. K., and Koenig, S. (1994) Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi. Nature 372, 552–555.
Vadolas, J., Davies, J. K., Wright, P. J., and Strugnell, R. A. (1995) Intranasal immunization with liposomes induces strong mucosal immune responses in mice. Eur. J. Immunol. 25, 969–975.
VanCott, J. L., Staats, H. F., Pascual, D. W., Roberts, M., Chatfield, S. N., Yamamoto, M., et al. (1996) Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J. Immunol. 156, 1504–1514.
Bukawa, H., Sekigawa, K., Hamajima, K., Fukushima, J., Yamada, Y., Kiyono, H., et al. (1995) Neutralization of HTV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate. Nat. Med. 1, 681–685.
Lowell, G. H., Kaminski, R. W., VanCott, T. C, Slike, B., Kersey, K., Zawoznik, et al. (1997) Nasal immunization with HIV gpl60 plus proteosomes, emulsomes and/or cholera toxin B subunit to induce serum, intestinal, lung and vaginal antibodies. J. Infect. Dis. 175, 292–301.
Lehner, T., Bergmeier, L. A., Panagiotidi, C., Tao, L., Brookes, R., Klavinskis, et al. (1992) Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science 258, 1365–1369.
Lehner, T., Bergmeier, L.A., Tao, L., Panagiotidi, C., Klavinskis, L.S., Hussain, L., et al. (1994) Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit genital, rectal, and urinary immune responses in nonhuman primates. J. Immunol. 153, 1858–1868.
Marx, P. A., Compans, R. W., Gettie, A., Staas, J. K., Gilley, R. M., Mulligan, M. J., et al. (1993) Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260, 1323–1327.
Lubeck, M. D., Natuk, R. J., Chengalvala, M., Chanda, P. K., Murthy, K. K., Murthy, S., et al. (1994) Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration. AIDS Res. Hum. Retrovir. 10, 1443–1449.
Orr, N., Arnon, R., Rubin, G., Cohen, D., Bercovier, H., and Lowell, G. H. (1994) Enhancement of anti-Shigella lipopolysaccharide (LPS) response by addition of the cholera toxin B subunit to oral and intranasal proteosome-Shigella flexneri 2a LPS vaccines. Infect. Immunol. 62, 5198–5200.
VanCott, T. C., Kaminski, R. W., Mascola, J. R. Kalyanaraman, V., Wassef, N., Alving, C., et al. (1998) HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160. J. Immunol. 160, 2000–2012.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Kaminski, R.W., VanCott, T.C. (1999). Collection and Processing of Mucosal Secretions from Mice. In: Michael, N.L., Kim, J.H. (eds) HIV Protocols. Methods in Molecular Medicine™, vol 17. Humana Press. https://doi.org/10.1385/0-89603-369-4:329
Download citation
DOI: https://doi.org/10.1385/0-89603-369-4:329
Publisher Name: Humana Press
Print ISBN: 978-0-89603-369-6
Online ISBN: 978-1-59259-601-0
eBook Packages: Springer Protocols